target

SYNTHORX

bidder

Sanofi

£1,902m

50 dealmakers

target

Forty Seven

bidder

Gilead Sciences

£3,821m

48 dealmakers

target

Tetra Therapeutics

bidder

SHIONOGI

£410m

23 dealmakers

target

Appharvest

bidder

Inclusive Capital

£779m

63 dealmakers

target

Viela Bio

bidder

Horizon Therapeutics

£2,262m

42 dealmakers

target

Five Prime Therapeutics

bidder

Amgen

£1,361m

34 dealmakers

target

Amplyx Pharmaceuticals

bidder

Pfizer

value n/a

29 dealmakers

target

Baylis Medical Company

bidder

Boston Scientific Corporation

£1,292m

36 dealmakers

target

BIOIQ

bidder

LETSGETCHECKED

value n/a

33 dealmakers

target

Lengo Therapeutics

bidder

Blueprint Medicines

£348m

57 dealmakers

target

Turning Point Therapeutics

bidder

Bristol Myers Squibb Company

£3,270m

56 dealmakers

target

Silverback Therapeutics

bidder

Ars Pharmaceuticals

£120m

46 dealmakers

target

Cincor Pharma

bidder

Astrazeneca

£1,487m

79 dealmakers

target

Elicio Therapeutics

bidder

Angion Biomedica Corp

value n/a

30 dealmakers

target

Tourmaline Bio

bidder

Talaris Therapeutics

value n/a

32 dealmakers

target

Travere Therapeutics (bile Acid Product Portfolio)

bidder

Mirum Pharmaceuticals

£366m

32 dealmakers

target

Propella Therapeutics

bidder

Astellas Pharma

£137m

41 dealmakers

target

Bridge To Life

bidder

TRANSMEDICS

value n/a

26 dealmakers

target

Carmot Therapeutics

bidder

Roche Holdings

£2,438m

49 dealmakers